 NEW YORK, July 18, 2021 PRNewswire -- Pomerantz LLP announces that a class action lawsuit has been filed against Frequency Therapeutics, Inc. Frequency or the Company NASDAQ: FREQ and certain of its officers. The class action, filed in the United States District Court for the District of Massachusetts, and docketed under 21-cv-11040, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Frequencys common stock between November 16, 2020 and March 22, 2021, inclusive the Class Period, seeking to pursue remedies under the Securities Exchange Act of 1934 the Exchange Act. 